Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: A post hoc analysis

International Journal of Geriatric Psychiatry

Volumn 16, Issue SUPPL. 1, 2001, Pages

  Mintzer, Jacobo ^a,b   Faison, Warachal ^a   Street, Jamie S ^c   Sutton, Virginia K ^c   Breier, Alan ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Anxiety; Atypical antipsychotics; Behavioral and Psychological Symptoms of Dementia (BPSD); Pharmacological treatment

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; OLANZAPINE; PIRENZEPINE;

AGED; ALZHEIMER DISEASE; ANXIETY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HOME FOR THE AGED; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; NURSING HOME; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANXIETY; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NURSING HOMES; PIRENZEPINE; TREATMENT OUTCOME;

EID: 0002618957     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1166(200112)16:1+<::aid-gps568>3.0.co;2-m     Document Type: Article

References (33)

1. Algozzine T, Pitner J, Mintzer J. 1999. The use of very-low-dose lorazepam for agitation in elderly persons with dementia. Consultant Pharmacist 14: 868-872.
2. Barnes TR. 1989. A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676.
3. Borson S, Raskind MA. 1997. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 48 (Suppl. 6): S17-S24.
4. Burns A, Jacoby R, Levy R. 1990. Psychiatric phenomena in Alzheimer's disease, Part I-IV. Br J Psychiatry 157: 72-94.
5. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gorbein J. 1994. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314.
6. De Deyn PP, Rabheur K, Rasmussen A, et al. 1999. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 53: 946-955.
7. Devanand DP, Sackeim HA, Brown RP, Mayeux R. 1989. A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease. Arch Neurol 46: 854-857.
8. Devanand DP, Marder K, Michaels KS, et al. 1998. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychoses and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 155: 1512-1520.
9. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-Mental State'. A practical method for grading the cognitive state of patients by the clinician. J Psychiatry Res 12: 189-198.
10. Guy W. 1976. ECDEU Assessment Manual for Psychopharmacology, revised edn. US Department of Health, Education, and Welfare: Bethesda.
11. Herrmann N, Eryavec G. 1993. Buspirone in the management of agitation and aggression associated with dementia. Am J Geriatr Psychiatry 1: 249-253.
12. Houlihan DJ, Mulsant BH, Sweet RA, et al. 1994. A naturalistic study of trazodone in the treatment of behavioral complications of dementia. Am J Geriatr Psychiatry 2: 78-85.
13. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitan J, Brecher M. 1999. For the risperidone study group. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 60: 107-115.
14. Lebert F, Pasquier B, Petit H. 1994. Behavioral effects of trazodone in Alzheimer's disease. J Clin Psychiatry 55: 536-538.
15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
16. McManus DQ, Arvanitis LA, Kowalcyk BB, and the Seroquel Trial 48 Study Group. 1999. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry 60: 292-298.
17. Mega MS, Cummings JL, Fiorello T, Gornbein J. 1996. The spectrum of behavioral chances in Alzheimer's disease. Neurology 46: 130-135.
18. Mintzer JE, Brawman-Mintnzer O. 1996. Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach. J Clin Psychiatry 57(suppl 7): 55-63.
19. Mintzer JE, Brawman-Mintzer O, Mirski D, Barkin K. 2000. Anxiety in the Behavioral and Psychological Symptoms of Dementia (BPSD). Int Psychogeriat 12(suppl 1): 139-142.
20. Nyth AL, Gottfries CG. 1990. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A nordic multicentre study. Br J Psychiatry 157: 894-901.
21. Nagaratnum N, Lewis-Jones M, Scott D, Palazzi L. 1998. Behavioral and psychiatric manifestations in dementia patients in a community: caregiver burden and outcome. Alz Dis Assoc Disord 12: 330-334.
22. Patel S, Tariot PR. 1995. Use of benzodiazepines in behaviorally disturbed patients: risk-benefit ratio. In Behavioral Complications of Alzheimer's Disease. Lawlor BA (ed.). American Psychiatric Press: Washington, DC; 153-170.
23. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. 1987. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 48(suppl): 9-15.
24. Sakauye KM, Camp CJ, Ford PA. 1993. Effects of buspirone on agitation associated with dementia. Am J Geriatr Psychiatry 1: 82-84.
25. Simpson GM, Angus JWS. 1970. A rating scale for extrapyramidal side effects. Acta Psychiat Scand 212: S11-S19.
26. Small GW, Rabins PV, Barry PP, Bucholtz NS, DeKosky ST, Ferris SH, et al. 1997. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278: 1363-1371.
27. Steele C, Rovner B, Chase G, Folstein M. 1990. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 147: 1049-1051.
28. Stern RG, Duffelmeyer ME, Zemishlani Z, Davidson M. 1991. The use of benzodiazepines in the management of behavioral symptoms in dementia patients. Psychiatr Clin North Am 14: 375-384.
29. Street JS, Clark WS, Gannon KS, et al. 2000. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 57: 968-976.
30. Tariot PN, Blazina L. 1994. The psychopathology of dementia. In Handbook of Dementing Illnesses. Morriss JC (ed.). Marcel Dekker: New York; 461-475.
31. Teri L, Ferretti LE, Gibbons LE, et al. Anxiety in Alzheimer's disease: prevalence and comorbidity. J Gerontol Med Sci 7: M348-M352.
32. Wood S, Cummings JL, Hsu M-A, Barclay T, Wheatley MV, Yarema KT, Schnelle JF. 2000. The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry 8: 75-83.
33. Zarit SH, Todd PA, Zarit JM. 1986. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 26: 260-266.